AdobeStock_319718852

NICE guideline

COVID-19 rapid guideline: delivery of systemic anticancer treatments

2021-02-18T11:53:00+00:00By

This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection

AdobeStock_340703775

PHE/DH/DWP guideline

PHE management of patient/staff exposure to COVID-19

2021-01-29T14:43:00+00:00By

This summary provides guidance on the management of staff and patients according to exposures, symptoms, and test results

vaccine older lady

PHE/DH/DWP guideline

NHS England COVID-19 vaccination SOP

2021-01-18T16:05:00+00:00By NHS England and NHS Improvement

This standard operating procedure (SOP) summary describes the operating model and design requirements for safe delivery of COVID-19 vaccines in the community

AdobeStock_329035023

NICE guideline

NICE ‘long COVID’ guideline

2020-12-18T13:56:00+00:00By , , Royal College of General Practitioners

Recommendations for identifying and managing ‘long-COVID’ in primary care

cat bite

NICE guideline

NICE guideline on the treatment of human and animal bites

2020-11-19T14:13:00+00:00By

This summary provides an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over. It aims to optimise antibiotic use and reduce antibiotic resistance.

urine infection

SIGN guideline

SIGN guideline on bacterial UTIs in women

2020-11-16T13:42:00+00:00By

This guidance provides advice on the managment of suspected bacterial lower urinary tract infection in adult women

Nurse writing notes_AS resized

NHS guideline

NHS England COVID-19 guidance for community pharmacy

2020-10-30T08:30:00+00:00By NHS England and NHS Improvement

This standard operating procedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation

AdobeStock_331083828

NICE guideline

COVID-19 rapid guideline: managing COVID-19 symptoms in the community

2020-10-22T00:00:00+01:00By

The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection

AdobeStock_335029203

PHE/DH/DWP guideline

PHE COVID-19 infection prevention and control guidance

2020-09-08T17:10:00+01:00By

Summary of the latest UK guidance on infection prevention and control measures for COVID-19.

AdobeStock_292279272

NICE guideline

COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response

2020-08-25T13:28:00+01:00By

The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.

Resource hub

  • WHO COVID-19 clinical management guideline

  • COVID-19 rapid guideline: delivery of systemic anticancer treatments

  • PHE management of patient/staff exposure to COVID-19

  • PHE influenza immunisation policy

  • PHE MenACWY vaccine guideline

  • WHO updates COVID-19 treatment guideline

  • General practice in the context of coronavirus (COVID-19)

  • NHS England COVID-19 vaccination SOP

  • PHE Zika virus guidance for pregnant women

  • NHIVNA annual health review